SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-15-001119
Filing Date
2015-12-24
Accepted
2015-12-24 13:01:21
Documents
1
Period of Report
2015-12-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4230
  Complete submission text file 0001562180-15-001119.txt   5534
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Issuer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address
AGARWAL SUNIL (Reporting) CIK: 0001616640 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36276 | Film No.: 151307738